The Role of PDE5 Inhibitors and the NO/cGMP Pathway in Cancer

Currently, there are inadequate data to make any conclusive statements regarding the role of PDE5i in cancer pathogenesis and how to alter clinical management. In order to create appropriate clinical guidelines, further experimental and clinical evidence is required.